Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Bohnenkamp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nursing|July 27, 2017
A nursing protocol for safe IVIG administrationTrevor J Barnum, Colleen Bohnenkamp, Sheila Haas
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 9, 2026
Tolerability and safety of a 3-step or 12-step chemotherapy desensitization protocolElizabeth Rybolt, Colleen Bohnenkamp, Vincent Cascone, et al.
JCO Oncology Advances|February 7, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 TrialQamar J Khan, Colleen Bohnenkamp, Taylor E Monson, et al.
JCO Oncology Practice|May 5, 2026
Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522Mara Lacy Hofherr, Andrew A Davis, Spenser January, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nursing|July 27, 2017
A nursing protocol for safe IVIG administrationTrevor J Barnum, Colleen Bohnenkamp, Sheila Haas
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 9, 2026
Tolerability and safety of a 3-step or 12-step chemotherapy desensitization protocolElizabeth Rybolt, Colleen Bohnenkamp, Vincent Cascone, et al.
JCO Oncology Advances|February 7, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 TrialQamar J Khan, Colleen Bohnenkamp, Taylor E Monson, et al.
JCO Oncology Practice|May 5, 2026
Real-World Analysis of Adverse Events in Patients With Triple-Negative Breast Cancer Receiving Therapy per KEYNOTE-522Mara Lacy Hofherr, Andrew A Davis, Spenser January, et al.
Pageof 1